FDA warns against Venom sibutramine supplements

By staff reporter

- Last updated on GMT

Related tags Food and drug administration

The US Food and Drug Administration (FDA) has warned the US public against a weight loss dietary supplement called Venom Hyperdrive 3.0 because it contains the banned pharmaceutical ingredient, sibutramine.

Sibutramine goes under the trade name Meridia in the US and Canada and Reductil in Europe and most other countries and is used as a weight loss agent in pharmaceutical products but is not approved for use in dietary supplements.

“Sibutramine, a controlled substance with risks for abuse or addiction, is a potent drug that poses potential safety risks,”​ FDA said in its advisory.

“Sibutramine is the active ingredient in an FDA-approved prescription drug used as an appetite suppressant for weight loss,”​ said Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research.

“But when present in a dietary supplement, it may harm unsuspecting consumers because sibutramine can substantially increase blood pressure and heart rate (pulse), and may present a significant risk for people with a history of heart disease, heart failure, irregular heart beats or stroke.”


Venom Hyperdrive 3.0 is based on a "herbal blend" ​and manufactured by Nevada-based Applied Lifescience Research Industries, which initiated a voluntary recall on the products after being informed by the FDA of the problem.

On its website the company said “trace amounts” ​of sibutramine were found in the Venom product, but FDA lab test showed “significant amounts of sibutramine per dosage unit.”

“Consumers who have this product should stop taking it immediately and contact their health care professional if they have experienced any adverse effects,” ​FDA said.

It said serious adverse events, side effects or product quality problems could be reported to its Adverse Event Reporting program either online, by regular mail, fax or phone.

Venom sold via US distributors and retail stores as well as in Canada, Poland, Sweden, Hungary, South Africa, the Netherlands, Australia, France and the United Kingdom.

Related news

Show more

Related products

show more

A Taste of Metabolic Health

A Taste of Metabolic Health

ADM | 21-Mar-2023 | Case Study

Are you ready to transform the way consumers support their metabolic health? Our latest case study featuring ADM’s propriety, awarding winning strain Bifidobacterium...

Phenylcapsaicin beyond weight management

Phenylcapsaicin beyond weight management

aXichem | 25-Oct-2022 | Technical / White Paper

Capsaicin, the active ingredient in chili peppers, is widely recognized as an effective natural ingredient for a variety of applications including topical...

Saffron patented extract, the appetite suppressant

Saffron patented extract, the appetite suppressant

Natac- Sustainable Botanical Extracts Manufacturer | 05-Oct-2022 | Technical / White Paper

Satiereal® (marketed as SupresaTM in North America) is the only clinically proven ingredient of saffron stigmas that has been shown to have a beneficial...

Follow us


View more